Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Published Online: 2016-07-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Akin Atmaca•Asim Amin•Chen-Sheng Lin•Christopher T Harbison•Dirk Jäger•Dung T Le•Emiliano Calvo•Filippo de Braud•Ian Chau•Jeffry Evans•Johanna Bendell•Joseph Paul Eder•José A López-Martin•Leora Horn•M Catherine Pietanza•Matthew Taylor•Michael A Morse•Olaf Christensen•Padmanee Sharma•Paolo A Ascierto•Patrick A Ott•Petri Bono•Rathi N Pillai•Scott J Antonia
